Interestingly, when RAGE antibodies were introduced into the prefrontal cortex, and hippocampus, Aβ deposition, and microglial activation were inhibited, thus highlighting RAGE as a potential therapeutic target for preventing AD, especially in post-sepsis older adults [33]. The gene discussed is AGER; the disease is Alzheimer disease.